Vanguard Asset Management
TEVA icon

Vanguard Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Vanguard Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Buy
425,294
+14,841
+4% +$494K 0.01% 609
2026
Q1 		$12.4M Buy
+410,453
New +$13.2M 0.01% 604

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vanguard Asset Management's TEVA Position: Q2 2026 in Review

Vanguard Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 3.6% in Q2 2026, buying an estimated $494K and bringing the position to 425,294 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #609.

Vanguard Asset Management first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 639 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Vanguard Asset Management held 425,294 shares of Teva Pharmaceuticals worth $14.4M as of Q2 2026.
  • Vanguard Asset Management bought 14,841 Teva Pharmaceuticals shares in Q2 2026, an estimated $494K.
  • Teva Pharmaceuticals made up 0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #609 holding.
  • Vanguard Asset Management first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 639 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.